Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat

Neuropharmacology. 2013 Mar:66:317-29. doi: 10.1016/j.neuropharm.2012.05.047. Epub 2012 Jul 13.

Abstract

Plastic changes in the amygdala and limbic cortex networks have been widely shown in chronic pain. We have here investigated the role of group I metabotropic glutamate receptors (mGluRs) in the basolateral amygdala (BLA) pre-infra-limbic (PL-IL) divisions of the medial prefrontal cortex (mPFC) neuron connections after carrageenan-induced inflammatory pain in the rat. Intra-plantar injection of carrageenan decreased either spontaneous or mechanically/electrically evoked activity of PL cortex pyramidal neurons which responded with excitation in a way prevented by CPCOOEt, a selective mGluR1 antagonist, though not by MPEP, a selective mGluR5 antagonist. Accordingly, intra-BLA microinjection of DHPG, a group I mGluR agonist, caused PL cortex neuron activity depression, antagonized by CPCCOEt. CPCOOEt, but not MPEP, reduced also carrageenan-induced mechanical allodynia. The PL cortex cell deactivation in inflammatory pain condition was associated with increased GABA (conversely glutamate was decreased) in the PL/IL cortex. The local application of bicuculline, a GABA(A) receptor selective antagonist, reduced mechanical allodynia. An over-expression of mGluR1, but not mGluR5, have been observed in the PL-IL cortex after inflammatory pain suggesting an increased mGluR1-dependent cross-talk among BLA and IL-PL cortex neurons in inflammatory pain conditions. This article is part of a Special Issue entitled 'Metabotropic Glutamate Receptors'.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Amygdala / drug effects
  • Amygdala / physiology*
  • Animals
  • Bicuculline / pharmacology
  • Carrageenan
  • Chromones / administration & dosage
  • Chromones / pharmacology
  • Disease Models, Animal
  • Electric Stimulation / methods
  • Excitatory Amino Acid Agonists / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Formaldehyde / pharmacology
  • GABA Antagonists / pharmacology
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Glycine / administration & dosage
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • Male
  • Neural Inhibition / drug effects
  • Neural Inhibition / physiology
  • Neural Pathways / drug effects
  • Neural Pathways / physiopathology
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology
  • Pain / physiopathology*
  • Physical Stimulation / methods
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / physiology*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / physiology
  • Pyridines / administration & dosage
  • Pyridines / pharmacology
  • Rats
  • Rats, Wistar
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate / biosynthesis
  • Receptors, Metabotropic Glutamate / physiology*
  • Resorcinols / administration & dosage
  • Resorcinols / pharmacology

Substances

  • 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester
  • Chromones
  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • GABA Antagonists
  • Grm5 protein, rat
  • Pyridines
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate
  • Resorcinols
  • metabotropic glutamate receptor type 1
  • Formaldehyde
  • 3,5-dihydroxyphenylglycine
  • 6-methyl-2-(phenylethynyl)pyridine
  • Carrageenan
  • Glycine
  • Bicuculline